GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » FCF Yield %

Shanghai Kehua Bio-engineering Co (SZSE:002022) FCF Yield % : -14.58 (As of May. 25, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Shanghai Kehua Bio-engineering Co's Trailing 12-Month Free Cash Flow is ¥-512 Mil, and Market Cap is ¥3,513 Mil. Therefore, Shanghai Kehua Bio-engineering Co's FCF Yield % for today is -14.58%.

The historical rank and industry rank for Shanghai Kehua Bio-engineering Co's FCF Yield % or its related term are showing as below:

SZSE:002022' s FCF Yield % Range Over the Past 10 Years
Min: -22.03   Med: 1.69   Max: 27.35
Current: -14.58


During the past 13 years, the highest FCF Yield % of Shanghai Kehua Bio-engineering Co was 27.35%. The lowest was -22.03%. And the median was 1.69%.

SZSE:002022's FCF Yield % is ranked worse than
71.26% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: -2.815 vs SZSE:002022: -14.58

Shanghai Kehua Bio-engineering Co's FCF Margin % for the quarter that ended in Mar. 2024 was -42.33%.


Shanghai Kehua Bio-engineering Co FCF Yield % Historical Data

The historical data trend for Shanghai Kehua Bio-engineering Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kehua Bio-engineering Co FCF Yield % Chart

Shanghai Kehua Bio-engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.81 13.99 11.31 27.13 -13.77

Shanghai Kehua Bio-engineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.80 -20.03 -0.78 -2.91 -18.31

Competitive Comparison of Shanghai Kehua Bio-engineering Co's FCF Yield %

For the Medical Devices subindustry, Shanghai Kehua Bio-engineering Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Kehua Bio-engineering Co's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai Kehua Bio-engineering Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Shanghai Kehua Bio-engineering Co's FCF Yield % falls into.



Shanghai Kehua Bio-engineering Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Shanghai Kehua Bio-engineering Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-805.823 / 5852.75676
=-13.77%

Shanghai Kehua Bio-engineering Co's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-187.656 * 4 / 4099.10649
=-18.31%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Kehua Bio-engineering Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Shanghai Kehua Bio-engineering Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Shanghai Kehua Bio-engineering Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Kehua Bio-engineering Co (SZSE:002022) Business Description

Traded in Other Exchanges
N/A
Address
No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
Executives
Li Ming Executives
He Jian Wen Executives
Ji Yu Ming Supervisors
Li Ji Executives
Sha Li Wu Director
Wang Man Directors, executives
Tang Wei Guo Director

Shanghai Kehua Bio-engineering Co (SZSE:002022) Headlines

No Headlines